Global Nuclear Receptor ROR-Gamma Market Size, Share, Trends and Forecast 2019

Description


The global Nuclear Receptor ROR-Gamma market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Nuclear Receptor ROR-Gamma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Receptor ROR-Gamma market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.

Segment by Regions
North America
Europe
China
Japan

Segment by Type
VPR-66
INV-17
GSK-2981278
BBI-6000
Others

Segment by Application
Hospital
Clinic
Others

TABLE OF CONTENT

Table of Contents

Executive Summary
1 Nuclear Receptor ROR-Gamma Market Overview
1.1 Product Overview and Scope of Nuclear Receptor ROR-Gamma
1.2 Nuclear Receptor ROR-Gamma Segment by Type
1.2.1 Global Nuclear Receptor ROR-Gamma Production Growth Rate Comparison by Type (2014-2025)
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Nuclear Receptor ROR-Gamma Segment by Application
1.3.1 Nuclear Receptor ROR-Gamma Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.3 Global Nuclear Receptor ROR-Gamma Market by Region
1.3.1 Global Nuclear Receptor ROR-Gamma Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Nuclear Receptor ROR-Gamma Market Size
1.4.1 Global Nuclear Receptor ROR-Gamma Revenue (2014-2025)
1.4.2 Global Nuclear Receptor ROR-Gamma Production (2014-2025)

2 Global Nuclear Receptor ROR-Gamma Market Competition by Manufacturers
2.1 Global Nuclear Receptor ROR-Gamma Production Market Share by Manufacturers (2014-2019)
2.2 Global Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2014-2019)
2.3 Global Nuclear Receptor ROR-Gamma Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Nuclear Receptor ROR-Gamma Production Sites, Area Served, Product Types
2.5 Nuclear Receptor ROR-Gamma Market Competitive Situation and Trends
2.5.1 Nuclear Receptor ROR-Gamma Market Concentration Rate
2.5.2 Nuclear Receptor ROR-Gamma Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nuclear Receptor ROR-Gamma Production Market Share by Regions
3.1 Global Nuclear Receptor ROR-Gamma Production Market Share by Regions
3.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Regions (2014-2019)
3.3 Global Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Nuclear Receptor ROR-Gamma Production
3.4.1 North America Nuclear Receptor ROR-Gamma Production Growth Rate (2014-2019)
3.4.2 North America Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Nuclear Receptor ROR-Gamma Production
3.5.1 Europe Nuclear Receptor ROR-Gamma Production Growth Rate (2014-2019)
3.5.2 Europe Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Nuclear Receptor ROR-Gamma Production (2014-2019)
3.6.1 China Nuclear Receptor ROR-Gamma Production Growth Rate (2014-2019)
3.6.2 China Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Nuclear Receptor ROR-Gamma Production (2014-2019)
3.7.1 Japan Nuclear Receptor ROR-Gamma Production Growth Rate (2014-2019)
3.7.2 Japan Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Nuclear Receptor ROR-Gamma Consumption by Regions
4.1 Global Nuclear Receptor ROR-Gamma Consumption by Regions
4.2 North America Nuclear Receptor ROR-Gamma Consumption (2014-2019)
4.3 Europe Nuclear Receptor ROR-Gamma Consumption (2014-2019)
4.4 China Nuclear Receptor ROR-Gamma Consumption (2014-2019)
4.5 Japan Nuclear Receptor ROR-Gamma Consumption (2014-2019)

5 Global Nuclear Receptor ROR-Gamma Production, Revenue, Price Trend by Type
5.1 Global Nuclear Receptor ROR-Gamma Production Market Share by Type (2014-2019)
5.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2014-2019)
5.3 Global Nuclear Receptor ROR-Gamma Price by Type (2014-2019)
5.4 Global Nuclear Receptor ROR-Gamma Production Growth by Type (2014-2019)

6 Global Nuclear Receptor ROR-Gamma Market Analysis by Applications
6.1 Global Nuclear Receptor ROR-Gamma Consumption Market Share by Application (2014-2019)
6.2 Global Nuclear Receptor ROR-Gamma Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Nuclear Receptor ROR-Gamma Business
7.1 4SC AG
7.1.1 4SC AG Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.1.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.1.3 4SC AG Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Advinus Therapeutics Ltd.
7.2.1 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.2.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Arrien Pharmaceuticals, LLC
7.3.1 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.3.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Aurigene Discovery Technologies Limited
7.4.1 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.4.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Biogen, Inc.
7.5.1 Biogen, Inc. Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.5.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Brickell Biotech, Inc.
7.6.1 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.6.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.7.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Celgene Corporation
7.8.1 Celgene Corporation Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.8.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.9.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Genfit SA
7.10.1 Genfit SA Nuclear Receptor ROR-Gamma Production Sites and Area Served
7.10.2 Nuclear Receptor ROR-Gamma Product Introduction, Application and Specification
7.10.3 Genfit SA Nuclear Receptor ROR-Gamma Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 GlaxoSmithKline Plc
7.12 Hanmi Pharmaceuticals, Co. Ltd.
7.13 Karo Bio AB
7.14 Lead Pharma Holding B.V.
7.15 Nuevolution AB
7.16 Phenex Pharmaceuticals AG
7.17 Reata Pharmaceuticals, Inc.
7.18 Teijin Pharma Limited
7.19 Visionary Pharmaceuticals, Inc.
7.20 Vitae Pharmaceuticals, Inc.

8 Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis
8.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma
8.4 Nuclear Receptor ROR-Gamma Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Nuclear Receptor ROR-Gamma Distributors List
9.3 Nuclear Receptor ROR-Gamma Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Nuclear Receptor ROR-Gamma Market Forecast
11.1 Global Nuclear Receptor ROR-Gamma Production, Revenue Forecast
11.1.1 Global Nuclear Receptor ROR-Gamma Production Growth Rate Forecast (2019-2025)
11.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Nuclear Receptor ROR-Gamma Price and Trend Forecast (2019-2025)
11.2 Global Nuclear Receptor ROR-Gamma Production Forecast by Regions (2019-2025)
11.2.1 North America Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2019-2025)
11.2.2 Europe Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2019-2025)
11.2.3 China Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2019-2025)
11.2.4 Japan Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2019-2025)
11.3 Global Nuclear Receptor ROR-Gamma Consumption Forecast by Regions (2019-2025)
11.3.1 North America Nuclear Receptor ROR-Gamma Consumption Forecast (2019-2025)
11.3.2 Europe Nuclear Receptor ROR-Gamma Consumption Forecast (2019-2025)
11.3.3 China Nuclear Receptor ROR-Gamma Consumption Forecast (2019-2025)
11.3.4 Japan Nuclear Receptor ROR-Gamma Consumption Forecast (2019-2025)
11.4 Global Nuclear Receptor ROR-Gamma Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Nuclear Receptor ROR-Gamma Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Choose License Type

Checkout Inquiry Sample